galantamine has been researched along with 1-hexadecyl-2-acetyl-glycero-3-phosphocholine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, HZ; Dong, CZ; Ezoulin, MJ; Heymans, F; Li, J; Massicot, F; Ombetta, JE; Wu, G | 1 |
Chen, HZ; Dong, CZ; Ezoulin, MJ; Heymans, F; Lelièvre, L; Li, J; Liu, Z; Massicot, F; Ombetta, JE | 1 |
2 other study(ies) available for galantamine and 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Article | Year |
---|---|
Differential effect of PMS777, a new type of acetylcholinesterase inhibitor, and galanthamine on oxidative injury induced in human neuroblastoma SK-N-SH cells.
Topics: Acetylcholinesterase; Alzheimer Disease; Butyrylcholinesterase; Cell Line, Tumor; Cell Survival; Cholinesterase Inhibitors; Encephalitis; Furans; Galantamine; Glutathione; Humans; Inflammation Mediators; Interleukin-1; Lipopolysaccharides; Mitochondria; Neuroblastoma; Neurons; Neuroprotective Agents; Oxidative Stress; Platelet Activating Factor; Reactive Oxygen Species | 2005 |
Study of PMS777, a new type of acetylcholinesterase inhibitor, in human HepG2 cells. Comparison with tacrine and galanthamine on oxidative stress and mitochondrial impairment.
Topics: Cell Survival; Cholinesterase Inhibitors; Furans; Galantamine; Humans; Lipid Peroxidation; Liver; Membrane Potentials; Mitochondria; Oxidative Stress; Platelet Activating Factor; Tacrine | 2006 |